1. Market Research
  2. > Therapy
25 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Over the Counter Drugs Market - Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • July 2020
  • 121 pages

Examples include cough and cold remedies, anti-fungal treatments, sunscreens, and non-prescription analgesics, such as aspirin and paracetamol.

  • OTC
  • Salicylic Acid
  • Bayer AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited

Pharmaceuticals Global Industry Almanac 2014-2023

  • $ 2995
  • April 2019
  • 538 pages

These products are offered under known brands such as Claritin, Aspirin, Aleve, Bepanthen/ Bepanthol, Canesten, Dr.

  • Pharmaceutical
  • Salicylic Acid
  • East Asia
  • Market Size
  • Takeda Pharmaceutical Company Limited

Gastrointestinal Drugs Market Global Briefing 2018

  • $ 1000
  • January 2018
  • 33 pages

Also, the increasing long-term use of nonsteroidal antiinflammatory drugs (NSAIDs) such as aspirin, ibuprofen, naproxen and diclofenac contributed to the market share of antiulcerants. xxxi Vitamins And Minerals was the second largest segment in the gastrointestinal drugs market accounting

  • Gastrointestinal Drug
  • Salicylic Acid
  • World
  • Allergan plc
  • Takeda Pharmaceutical Company Limited

Global Peptic Ulcer Drugs Market 2017-2021

  • $ 2500
  • July 2017
  • 84 pages

MARCH 2014: TAKEDA PHARMACEUTICAL ANNOUNCES THE NDA FILING FOR TAKELDA, WHICH IS A FIXED-DOSE COMBINATION TABLET OF ASPIRIN AND LANSOPRAZOLE.

  • Anti-Infective
  • Digestive System Disorder
  • Salicylic Acid
  • Therapy
  • Takeda Pharmaceutical Company Limited

Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022)

  • $ 2400
  • July 2017
  • 210 pages

aspirin, tetracycline, cocaine Metabolic Lipodystrophy, hypopituitarism, dysbetalipoproteinaemia, Weber-Christian disease Infections Human immunodeficiency virus, hepatitis C, small bowel diverticulosis with bacterial overgrowth Fatty Liver Disease Market Outlook this damage is permanent an

  • Digestive System Disorder
  • Pathology
  • Salicylic Acid
  • World
  • Takeda Pharmaceutical Company Limited

Incretion Drugs Companies in China

  • $ 1800
  • October 2019
  • 89 pages

BAYER OF GERMANY, THE INVENTOR OF ASPIRIN, BEGAN TRADE WITH CHINA IN AS EARLY AS ##.

  • Pharmaceutical
  • Salicylic Acid
  • China
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

Karolinska Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 126 pages

It was found that after eight weeks, the increase in muscle volume, as measured by MR imaging, was twice as large in the low-dose aspirin group as in the high-dose ibuprofen group.

  • Hepatitis
  • Salicylic Acid
  • Therapy
  • Sweden
  • Takeda Pharmaceutical Company Limited

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

  • $ 4995
  • June 2017
  • 140 pages

These include NSAIDs such as aspirin, diclofenac, ibuprofen and Celebrex (celecoxib), and analgesics (painkillers), such as codeine.

  • Autoimmune Disease
  • Immunology
  • Salicylic Acid
  • Therapy
  • Takeda Pharmaceutical Company Limited

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

  • $ 4995
  • December 2016
  • 110 pages

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline Summary Hypertension is a serious and common medical condition ...

  • Antihypertensive
  • Cardiovascular Drug
  • Hypertension
  • Therapy
  • Takeda Pharmaceutical Company Limited

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments

  • $ 4995
  • December 2016
  • 133 pages

For example, non-steroidal antiinflammatory drugs, opioids and non-opioid analgesics are used to treat pain that arises in a significant portion of ALS patients, and a number of antidepressants and antipsychotics are used to treat the mental symptoms of the condition.

  • Clinical Trial
  • Dementia
  • Therapy
  • Biogen Idec Inc.
  • Takeda Pharmaceutical Company Limited

Over the Counter (OTC) Analgesics Market - Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • March 2020
  • 110 pages

Some of the established salicylates in the market include aspirin, magnesium salicylate, and sodium salicylate and trolamine salicylate.

  • Analgesic
  • OTC
  • Pharmaceutical
  • Salicylic Acid
  • Takeda Pharmaceutical Company Limited

Global GERD Market 2016-2020

  • $ 2500
  • January 2016
  • 84 pages

In December 2014, Pariet received approval for the prevention of recurrent gastric or duodenal ulcers caused by low-dose aspirin therapy in Japan.

  • Gastrointestinal Drug
  • Salicylic Acid
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Takeda Pharmaceutical Company Limited

OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecast to 2025

  • $ 10995
  • November 2016
  • 288 pages

THE PRICE OF NSAIDS WAS DETERMINED FROM THE AVERAGE PRICE OF NAPROXEN, IBUPROFEN, AND ASPIRIN (ASPIRIN, ASPIRINETTA) MADE BY DIFFERENT MANUFACTURERS IN ITALY.

  • Genitourinary System Disease
  • Salicylic Acid
  • Japan
  • United States
  • Takeda Pharmaceutical Company Limited

Sleep Disorders Global Clinical Trials Review, H1, 2020

  • $ 2500
  • February 2020
  • 977 pages

aspirin; spironolactone; undisclosed angiotensin converting enzyme inhibitor; undisclosed angiotensin II receptor blocker; undisclosed beta blocker; undisclosed loop diuretic; undisclosed statin; warfarin ResMed Foundation ## Dec 2013 ## Dec 2015 ## ## ## ## ## Study of the Efficacy and

  • Clinical Trial
  • Neurology
  • Salicylic Acid
  • Sleep Aid
  • Takeda Pharmaceutical Company Limited

Hyperuricemia Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020
  • 260 pages

Aspirin on Uric Acid in Chinese Patients with Coronary Artery Disease(AURORA): A Prospective Cohort Study The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients with Coronary Artery Disease(AURORA) (AURORA) GDCT## NCT##, Metabolic Disorders Coronary Ar

  • Clinical Trial
  • Endocrine Disease
  • Salicylic Acid
  • Therapy
  • Takeda Pharmaceutical Company Limited

South Africa Central Nervous System Therapeutic Market to 2027 - Regional Analysis and Forecasts by Disease Type, Drug Type, Distribution Channel and Geography

  • $ 3000
  • September 2019
  • 76 pages

They include paracetamol (acetaminophen), the nonsteroidal anti-inflammatory drugs (NSAIDs) such as the narcotic drugs such as morphine, salicylates, synthetic drugs with narcotic properties such as tramadol, and others.

  • Neurology
  • Salicylic Acid
  • South Africa
  • Southern Africa
  • Takeda Pharmaceutical Company Limited

Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies – 2016 Update

  • $ 570
  • May 2016
  • 124 pages

Amgen Annual Report 2015 - Initiated phase III study in the US sBLA Antibody II Kawasaki Disease ClinicalTrials. gov Dec 2015 - Investigator-sponsored study to determine whether Enbrel when used in conjunction with IVIG and aspirin, improves treatment response to IVIG in patients with Kawas

  • Biosimilar
  • Salicylic Acid
  • Amgen Inc.
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited

Insomnia Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020
  • 524 pages

aspirin Beth Israel Deaconess Medical Center Inc ## Oct 2014 ## Oct 2016 ## ## ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Biomarker(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Estimat

  • Clinical Trial
  • Neurology
  • Salicylic Acid
  • Sleep Aid
  • Takeda Pharmaceutical Company Limited

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies – 2016 Update

  • $ 1482
  • May 2016
  • 462 pages

Amgen Annual Report 2015 - Initiated phase III study in the US sBLA Message Antibody II Kawasaki Disease ClinicalTrials. gov Dec 2015 - Investigator-sponsored study to determine whether Enbrel when used in conjunction with IVIG and aspirin, improves treatment response to IVIG in patients wi

  • Biosimilar
  • Pharmaceutical
  • Salicylic Acid
  • Roche Group
  • Takeda Pharmaceutical Company Limited

Sleep Disorders Global Clinical Trials Review, H2, 2018

  • $ 2500
  • July 2018
  • 826 pages

aspirin; spironolactone; undisclosed angiotensin converting enzyme inhibitor; undisclosed angiotensin II receptor blocker; undisclosed beta blocker; undisclosed loop diuretic; undisclosed statin; warfarin ResMed Foundation ## Dec 2013 ## Dec 2015 ## ## ## ## ## Randomized Controlled Tria

  • Clinical Trial
  • Neurology
  • Salicylic Acid
  • Sleep Aid
  • Takeda Pharmaceutical Company Limited

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on